Every week we screen the WHO International Clinical Trials Registry Platform (ICTRP) to identify and extract data from RCTs evaluating the effectiveness of interventions for preventing and treating COVID-19 as well as of all trials assessing vaccines. This data is being used to develop our two living data visualizations of treatments and vaccines. This dataset includes a detailed list of all the RCTs we have identified, including their characteristics (i.e. registration date, study design, study aim, funding, country, etc.). This file is updated once a week.
We are willing to make our database freely available to people who request it for legitimate research.
If you wish to download the database for the first time, you need to create an account by filling the form below. It is important for us to know who is using our data and for which scope.
If you already have an account and you want to access a new version of the database, you can login using your email and password.
How is our work copyrighted?
Data and visualizations: All our data and visualizations are licensed under the CC-BY license (CC-BY-4.0). The BY stands for ‘by attribution’ and this means you are free to take whatever is useful for your work. You just need to provide credit to the COVID-NMA initiative (see below).
How can you reproduce or cite our work in your publication?
We require that whenever you use our work for a publication, you stick to the following guidelines:
Why do we ask for personal data?
It is important for us to know who is downloading our data.
The information you provide will be solely used to contact you, if necessary, to have more information on the intended use of our data. Personal information will be stored on a secure server managed by the CRESS Université de Paris.
You have the right to access, amend and delete all your personal data, which have been collected as part of your registration. As such, you may at any time contact us at data *a t* covid-nma.com.
To create a new account and have access to our data, please fill the form below